Novo Holdings, TA Associates agree Biocomposites investment

The transaction gives TA and Novo Holdings shared control of Biocomposites.

  • Biocomposites is a medical devices company
  • Biocomposites is headquartered in Keele, UK
  • TA has been Biocomposites’ majority shareholder since 2017

Novo Holdings and TA Associates have agreed to make an investment into Biocomposites.

Biocomposites is a medical devices company that engineers, manufactures and markets leading products for use in infection management in bone and soft tissue.

Share this